Status:
RECRUITING
Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
Lead Sponsor:
University of Chicago
Conditions:
Cirrhosis, Liver
Diabetes Mellitus Risk
Eligibility:
All Genders
18-75 years
Brief Summary
The goal of this observational study is to establish risk factors for post-transplant in adult individuals with cirrhosis without diabetes undergoing liver transplant evaluation. The question being a...
Detailed Description
Participants will be enrolled from the liver transplant clinic and will be given a continuous glucose monitor, a wrist actigraph, a home sleep apnea testing device, and a questionnaire packet to colle...
Eligibility Criteria
Inclusion
- Patients presenting to liver transplant clinic with a diagnosis of cirrhosis.
- Age \>18 yrs.
- Ability to understand and sign written consent form, or have a legally-authorized representative or proxy who can be approached for consent
Exclusion
- Patients without consent
- Patients with implantable cardioverter defibrillator devices or automated implantable cardioverter defibrillator devices will be excluded from the bio-electrical impedance analysis portion of the measurements.
- Patients with unremovable electrical medical devices or devices that cannot turn off will be excluded from the bio-electrical impedance analysis measurements
- Pregnant patients
- Incarcerated patients
- Patients with a history of type 2 diabetes mellitus diagnosed \> 5 years ago will be excluded from the Oral Glucose Tolerance Test portion of the study
Key Trial Info
Start Date :
March 12 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2031
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06950788
Start Date
March 12 2024
End Date
January 1 2031
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago Medical Center
Chicago, Illinois, United States, 60637